Perspective Therapeutics (CATX) Finished Goods (2011 - 2023)

Perspective Therapeutics has disclosed Finished Goods across 11 years of filings, most recently posting $20000.0 for Q3 2023.

• In Q3 2023, Finished Goods fell 25.93% year-over-year to $20000.0; the TTM figure through Sep 2023 stood at $20000.0 (down 25.93% YoY), while the FY2022 annual figure was $21000.0, changed N/A from the prior year.
• Finished Goods came in at $20000.0 for Q3 2023 at Perspective Therapeutics, up from $18000.0 in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $49000.0 in Q2 2021 to a low of $7000.0 in Q4 2019.
• Average Finished Goods over 5 years is $22368.4, with a median of $21000.0 recorded in 2022.
• Year-over-year, Finished Goods sank 72.97% in 2019 and surged 314.29% in 2021.
• Over 5 years, Finished Goods stood at $7000.0 in 2019, then changed by 0.0% to $7000.0 in 2020, then surged by 314.29% to $29000.0 in 2021, then fell by 27.59% to $21000.0 in 2022, then retreated by 4.76% to $20000.0 in 2023.
• Per Business Quant data, the three most recent Finished Goods figures were $20000.0 in Q3 2023, $18000.0 in Q2 2023, and $15000.0 in Q1 2023.